The complex interaction of different proinflammatory factors (such as interleukin-6 or TNF-α) with anti-inflammatory cytokines (TGF-α and TGF-β) and their signaling pathways is involved in the occurrence and development of liver cancer [32]. This evidence concerns the gene IL6 and liver cancer.